Stockreport

GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen® [Yahoo! Finance]

GoodRx Holdings, Inc. - Class A  (GDRX) 
PDF Brief Summary: GoodRx to collaborate with Eli Lilly to expand employer-sponsored access to Zepbound® KwikPen®, an FDA-approved dual GIP and GLP-1 obesity treatment [Read more]